» Articles » PMID: 12839925

Induction of Carcinogenesis by Concurrent Inactivation of P53 and Rb1 in the Mouse Ovarian Surface Epithelium

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Jul 4
PMID 12839925
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

Alterations in p53 and Rb pathways are observed frequently in epithelial ovarian cancer (EOC).However, their roles in EOC initiation remain uncertain. Using a single intrabursal administration of recombinant adenovirus expressing Cre, we demonstrate that concurrent inactivation of p53 and Rb1 is sufficient for reproducible induction of ovarian epithelial carcinogenesis in mice homozygous for conditional gene alleles. Similarly to progression of disease in women, ovarian neoplasms spread i.p., forming ascites, and metastasize to the contralateral ovary, the lung, and the liver. These results establish critical interactions between p53 and Rb1 pathways in EOC pathogenesis, and provide a genetically defined immunocompetent mouse model of sporadic EOC.

Citing Articles

Aggressive Serous Carcinomas of the Female Reproductive Tract: Cancer-Prone Cell States and Genetic Drivers.

Phuong D, Pirtz M, Ralston C, Cosgrove B, Schimenti J, Flesken-Nikitin A Cancers (Basel). 2025; 17(4).

PMID: 40002199 PMC: 11852459. DOI: 10.3390/cancers17040604.


Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma.

Flesken-Nikitin A, Ralston C, Fu D, De Micheli A, Phuong D, Harlan B Nat Commun. 2024; 15(1):8641.

PMID: 39366996 PMC: 11452611. DOI: 10.1038/s41467-024-52984-1.


Cancer metastases: Tailoring the targets.

Pote M, Singh D, M A A, Suchita J, Gacche R Heliyon. 2024; 10(15):e35369.

PMID: 39170575 PMC: 11336595. DOI: 10.1016/j.heliyon.2024.e35369.


Biology-driven therapy advances in high-grade serous ovarian cancer.

Wang Y, Duval A, Adli M, Matei D J Clin Invest. 2024; 134(1).

PMID: 38165032 PMC: 10760962. DOI: 10.1172/JCI174013.


Epithelial Ovarian Cancer: A Five Year Review.

Arnaoutoglou C, Dampala K, Anthoulakis C, Papanikolaou E, Tentas I, Dragoutsos G Medicina (Kaunas). 2023; 59(7).

PMID: 37511995 PMC: 10384230. DOI: 10.3390/medicina59071183.